WHO ICTRP trial
A randomized, double-blind, placebo-controlled, multicenter clinical trial for…
ChiCTR1800019754 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR1800019754 |
|---|---|
| Public title | A randomized, double-blind, placebo-controlled, multicenter clinical trial for the effectiveness and safety of Shuxuening injection in the treatment of unstable angina |
| Scientific title | A randomized, double-blind, placebo-controlled, multicenter clinical trial for the effectiveness and safety of Shuxuening injection in the treatment of unstable angina |
| Primary sponsor | Dongfang Hospital, Beijing University of Chinese Medicine |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | Post-market |
| Countries | China |
| Conditions | Unstable angina |
| Interventions | Experimental group:Shuxuening injection+basic treatment;Control group :Placebo(Sterile Water for Injection)+basic treatmen |
| Registration date | Nov 26, 2018 |
| Target size | Experimental group:360;Control group :120 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: